WINTON GROUP Ltd trimmed its holdings in shares of Walgreens Boots Alliance Inc (NASDAQ:WBA) by 48.5% during the 3rd quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 77,778 shares of the pharmacy operator’s stock after selling 73,124 shares during the quarter. WINTON GROUP Ltd’s holdings in Walgreens Boots Alliance were worth $6,006,000 at the end of the most recent quarter.
A number of other institutional investors have also bought and sold shares of the business. Hudock Capital Group LLC boosted its holdings in Walgreens Boots Alliance by 0.5% during the second quarter. Hudock Capital Group LLC now owns 1,306 shares of the pharmacy operator’s stock valued at $102,000 after acquiring an additional 6 shares during the period. Westside Investment Management Inc. boosted its holdings in Walgreens Boots Alliance by 10.4% during the second quarter. Westside Investment Management Inc. now owns 1,325 shares of the pharmacy operator’s stock valued at $102,000 after acquiring an additional 125 shares during the period. IHT Wealth Management LLC boosted its holdings in Walgreens Boots Alliance by 46.3% during the second quarter. IHT Wealth Management LLC now owns 6,946 shares of the pharmacy operator’s stock valued at $135,000 after acquiring an additional 2,199 shares during the period. Bristlecone Advisors LLC bought a new stake in Walgreens Boots Alliance during the third quarter valued at about $135,000. Finally, Private Vista LLC boosted its holdings in Walgreens Boots Alliance by 6,403.7% during the second quarter. Private Vista LLC now owns 583,185 shares of the pharmacy operator’s stock valued at $140,000 after acquiring an additional 574,218 shares during the period. 61.18% of the stock is currently owned by hedge funds and other institutional investors.
WBA has been the subject of a number of recent analyst reports. Jefferies Group restated a “buy” rating and set a $95.00 price target on shares of Walgreens Boots Alliance in a report on Thursday, September 7th. Needham & Company LLC reiterated a “buy” rating and issued a $94.00 target price on shares of Walgreens Boots Alliance in a research note on Sunday, September 10th. BidaskClub cut shares of Walgreens Boots Alliance from a “hold” rating to a “sell” rating in a research note on Tuesday, September 12th. Royal Bank of Canada initiated coverage on shares of Walgreens Boots Alliance in a research note on Tuesday, September 19th. They issued an “outperform” rating and a $96.00 target price for the company. Finally, Raymond James Financial reiterated a “market perform” rating on shares of Walgreens Boots Alliance in a research note on Wednesday, September 27th. One investment analyst has rated the stock with a sell rating, eight have assigned a hold rating, fifteen have issued a buy rating and one has issued a strong buy rating to the stock. Walgreens Boots Alliance has an average rating of “Buy” and an average target price of $86.70.
Walgreens Boots Alliance Inc (NASDAQ:WBA) opened at $71.60 on Friday. The company has a market cap of $70,910.00, a PE ratio of 18.94, a price-to-earnings-growth ratio of 1.34 and a beta of 1.22. The company has a debt-to-equity ratio of 0.45, a quick ratio of 0.59 and a current ratio of 1.07. Walgreens Boots Alliance Inc has a one year low of $63.82 and a one year high of $88.00.
Walgreens Boots Alliance (NASDAQ:WBA) last announced its quarterly earnings results on Thursday, January 4th. The pharmacy operator reported $1.28 EPS for the quarter, topping analysts’ consensus estimates of $1.24 by $0.04. The firm had revenue of $30.74 billion during the quarter, compared to analysts’ expectations of $30.39 billion. Walgreens Boots Alliance had a net margin of 3.45% and a return on equity of 18.36%. The company’s revenue for the quarter was up 7.9% compared to the same quarter last year. During the same quarter last year, the company earned $1.10 earnings per share. equities analysts expect that Walgreens Boots Alliance Inc will post 5.54 EPS for the current year.
The firm also recently declared a quarterly dividend, which was paid on Tuesday, December 12th. Shareholders of record on Monday, November 13th were paid a dividend of $0.40 per share. This represents a $1.60 dividend on an annualized basis and a yield of 2.23%. The ex-dividend date of this dividend was Friday, November 10th. Walgreens Boots Alliance’s dividend payout ratio is 42.33%.
Walgreens Boots Alliance announced that its board has authorized a stock buyback program on Wednesday, October 25th that permits the company to buyback $1.00 billion in shares. This buyback authorization permits the pharmacy operator to reacquire shares of its stock through open market purchases. Shares buyback programs are typically an indication that the company’s management believes its stock is undervalued.
In other news, Director William C. Foote sold 2,736 shares of the firm’s stock in a transaction that occurred on Thursday, November 2nd. The shares were sold at an average price of $67.37, for a total transaction of $184,324.32. Following the completion of the sale, the director now owns 16,415 shares of the company’s stock, valued at $1,105,878.55. The transaction was disclosed in a document filed with the SEC, which is accessible through this link. Also, Director John Anthony Lederer acquired 20,000 shares of the company’s stock in a transaction dated Thursday, October 26th. The shares were purchased at an average cost of $67.00 per share, with a total value of $1,340,000.00. Following the acquisition, the director now owns 50,000 shares of the company’s stock, valued at approximately $3,350,000. The disclosure for this purchase can be found here. 14.80% of the stock is owned by company insiders.
TRADEMARK VIOLATION NOTICE: This article was originally posted by Transcript Daily and is the sole property of of Transcript Daily. If you are accessing this article on another site, it was illegally stolen and republished in violation of U.S. & international copyright and trademark laws. The legal version of this article can be accessed at https://transcriptdaily.com/2018/01/05/winton-group-ltd-has-6-01-million-holdings-in-walgreens-boots-alliance-inc-wba.html.
About Walgreens Boots Alliance
Walgreens Boots Alliance, Inc (Walgreens Boots Alliance) is a holding company. The Company is a global pharmacy-led, health and wellbeing enterprise. Walgreens Boots Alliance operates through three divisions, including Retail Pharmacy USA, Retail Pharmacy International and Pharmaceutical Wholesale. The Company’s products are marketed under a number of brands, which include No7, the Botanics range, Almus (generic medicines), Boots Pharmaceuticals and Soap & Glory (bathing and beauty brand).
Want to see what other hedge funds are holding WBA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Walgreens Boots Alliance Inc (NASDAQ:WBA).
Receive News & Ratings for Walgreens Boots Alliance Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Walgreens Boots Alliance and related companies with MarketBeat.com's FREE daily email newsletter.